Puma Biotechnology, Inc.
PBYI
$5.06
$0.193.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.47% | 229.28% | 161.77% | 57.36% | 250.53% |
| Total Depreciation and Amortization | -5.42% | -4.99% | -3.49% | -1.66% | 0.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.02% | -32.62% | -9.97% | -51.63% | -36.72% |
| Change in Net Operating Assets | 76.41% | 445.90% | -141.18% | -5.23% | -1,054.28% |
| Cash from Operations | -12.22% | 1,271.18% | -67.88% | 49.28% | 3.98% |
| Capital Expenditure | -30.00% | 0.00% | -- | 64.44% | 25.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.68% | -1,652.97% | 108.34% | 71.64% | -97.51% |
| Cash from Investing | 95.37% | -1,700.00% | 108.02% | 71.60% | -97.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.45% | 0.00% | -- | -- | -- |
| Cash from Financing | -1.33% | 1.15% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,097.37% | 12.85% | 21.00% | -14.40% | -99.48% |